See all request types:

Congresses & events

Funding to healthcare or healthcare-related organizations, institutions, or entities acting on their behalf, to support a congress or event in exchange for which Biogen receives tangible benefits such as recognition, display, and/or marketing opportunities.

  • Areas of Interest

    Biogen considers requests across a variety of disease and focus areas, including, but not limited to: Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Biosimilars, Chemistry, Drug Development, Fibrosis, Lupus, Lymphoma, Multiple Sclerosis, Myotonic Dystrophy, Neuropathic Pain, Ophthalmology, Parkinson’s Disease, Pharmacology, Sjogren’s Syndrome, Spinal Muscular Atrophy, Stroke, Trigeminal Neuralgia, and other Neurological disease areas.

  • How to Apply

    Sponsorship requests for congresses & events will be reviewed on a rolling basis. Requests must be submitted 60 days in advance of when a funding decision is needed by the organization. Biogen reserves the right to decline any applications not adhering to the deadline.  

  • Funding Requirements

    Sponsorship requests must clearly identify the tangible benefit offered to Biogen and the value of the tangible benefit must be reasonable and generally consistent with norms for comparable events or benefits. The sponsorship opportunity must be generally and genuinely available to other potential sponsors.

  • Funding Restrictions & Limitations

    To ensure the independence of our applicants, Biogen will review an organization's annual operating expenses against the level of individual and aggregate funding Biogen provided to the organization on a rolling twelve (12) month basis. 

    Sponsorships whose sole purpose is to fund an organization’s general operating costs, routine business expenses, or capital costs (infrastructure), or political or lobbying activities are not eligible for funding.

  • Review Process and Decision

    Sponsorship requests will be reviewed on a rolling basis. Requests must be submitted 60 days in advance of when a funding decision is needed by the organization.

    Biogen’s approval is based on several criteria including, but not limited to, our funding availability, areas of interest alignment, the event details and agenda, and the region/geographic location where the event is taking place.

    In all cases, Biogen notifies applicants of our decision by email.  Notification of decision shall only be communicated by the Grants Management & Strategic Giving office and no other Biogen staff member is authorized to approve or decline requests.  We receive many qualified and deserving applications and regret that we cannot fund all of them. All applications receive a fair review, and we encourage organizations to reapply for future programs and initiatives.

  • Contracting

    All recipient organizations must abide by the terms and conditions as outlined in the Biogen Letter of Agreement (LOA), which is issued electronically to an authorized signatory of your organization once the application is approved. The organization must agree to the terms of the LOA before any payment is processed.

  • Program Execution

    If the scope of an approved program or activity changes, organizations must submit such changes via the Biogen Grants & Giving Portal in advance of such changes. Biogen will review the scope changes and assess whether funding for the activity should continue.

  • Reconciliation

    Recipient organizations must confirm receipt of funds and attest that funds were used for the purposes described in the contract. The approved use of funding must be reconciled, or assessed against the actual use of that funding, and reconciliation must be documented. 

    Failure of organizations to appropriately reconcile by the due date may delay further funding or cause denial of further applications.

Submit your proposal